Pulse Biosciences (PLSE) Enterprise Value (2020 - 2025)
Historic Enterprise Value for Pulse Biosciences (PLSE) over the last 6 years, with Q3 2025 value amounting to -$95.2 million.
- Pulse Biosciences' Enterprise Value fell 2047.37% to -$95.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$95.2 million, marking a year-over-year decrease of 2047.37%. This contributed to the annual value of -$118.0 million for FY2024, which is 16606.11% down from last year.
- As of Q3 2025, Pulse Biosciences' Enterprise Value stood at -$95.2 million, which was down 2047.37% from -$106.3 million recorded in Q2 2025.
- Pulse Biosciences' Enterprise Value's 5-year high stood at -$12.7 million during Q1 2022, with a 5-year trough of -$119.3 million in Q1 2025.
- Over the past 5 years, Pulse Biosciences' median Enterprise Value value was -$54.1 million (recorded in 2023), while the average stood at -$59.9 million.
- As far as peak fluctuations go, Pulse Biosciences' Enterprise Value crashed by 45373.19% in 2021, and later soared by 7883.21% in 2022.
- Over the past 5 years, Pulse Biosciences' Enterprise Value (Quarter) stood at -$44.4 million in 2021, then plummeted by 37.81% to -$61.1 million in 2022, then rose by 27.44% to -$44.4 million in 2023, then tumbled by 166.06% to -$118.0 million in 2024, then grew by 19.34% to -$95.2 million in 2025.
- Its last three reported values are -$95.2 million in Q3 2025, -$106.3 million for Q2 2025, and -$119.3 million during Q1 2025.